A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions

Authors: Strauss, R.M.1; Elliott, F.2; Affleck, P.2; Boon, A.P.3; Newton-Bishop, J.A.

Source: British Journal of Dermatology, Volume 157, Number 4, October 2007 , pp. 758-764(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Summary Background 

Atypical naevi are common benign skin lesions but are also recognized both as precursors of and risk factors for melanoma. It is therefore imperative to excise those lesions that are either likely to progress or are already progressing to melanoma. Clinically, however, it may be difficult to distinguish these from benign atypical naevi with bland histology. Objectives 

To analyse the clinical characteristics of excised melanocytic lesions and to identify the predictors of severe histological atypia/melanoma in situ and invasive melanoma. Methods 

The case notes of 434 patients who had melanocytic lesions removed at a pigmented lesion clinic were studied retrospectively. A single pathologist reviewed the excised lesions and clinical characteristics predictive of malignancy were identified. Results 

The best predictors of melanoma were older age, history of change and site on an extremity, but only older age was predictive of severe histological atypia/melanoma in situ as opposed to mild to moderate atypical histology. Conclusions 

These results confirm the difficulty of differentiating accurately between benign atypical naevi and borderline lesions or early melanoma in a clinical setting. It is therefore necessary to have a sufficiently low threshold for excision to avoid missing early melanomas, particularly in older patients presenting with lesions on the extremities.

Keywords: atypical naevi; diagnosis; melanoma

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1365-2133.2007.08136.x

Affiliations: 1: Department of Dermatology, Leeds General Infirmary and St James's University Hospital, Leeds LS9 7TF, U.K. 2: Division of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds, U.K. 3: Department of Histopathology, St James's University Hospital, Leeds, U.K.

Publication date: 2007-10-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page